Company profile

Inofea AG

INOFEA was created to meet a critical need of the industry: to make enzymes more stable, re-usable and suitable for continuous processes. We immobilize enzymes and protect them with a tailor-made shield, making them easy to use in biocatalysis, bioanalysis, proteomics and as an active ingredient. Our customers are among the top players in their industry, namely Pharma, Food & Feed, Specialty Chemicals and Consumer Care. Our technology allows a reduction of raw materials needed for synthesis, a reduction of energy consumption during the production process and a reduction of waste and solvents in biocatalytic processes.

More news about Inofea AG

08.01.2021 15:21

BAS members invested a 7-digit amount in start-ups in 2020

Please login or
register to use the
awards follow feature
30.06.2020 16:55

The EIT Food cohort of 2020 is ready for the acceleration journey

Please login or
register to use the
awards follow feature
19.06.2020 10:37

Nine start-ups on a virtual stage

Please login or
register to use the
awards follow feature
28.04.2020 10:40

INOFEA enters longterm collaboration with the global pharma company UCB

Please login or
register to use the
awards follow feature
25.06.2018 15:40

From Tesla, Thomson Reuters and Schoeller to startups

Please login or
register to use the
awards follow feature
04.12.2017 16:05

INOFEA closes 2nd tranche of Series A+ financing round

Please login or
register to use the
awards follow feature
07.04.2017 14:26

INOFEA closes oversubscribed financing round

Please login or
register to use the
awards follow feature
10.04.2014 15:06

Three companies awarded with the CTI start-up label

Please login or
register to use the
awards follow feature
31.10.2013 11:24

Swiss Technology Award: Finalisten stehen fest

Please login or
register to use the
awards follow feature
Inofea AG

Founded
2014

Kanton
Basel-Stadt


LinkedIn

Homepage

rss